GlaxoSmithKline plc (ADR)

The U.S. Food and Drug Administration on Thursday approved a long-acting HIV injection from British drugmaker GlaxoSmithKline's HIV treatment division, ViiV Healthcare.

Merck KGaA's drug development programme has suffered a setback with its most important experimental drug, cancer treatment bintrafusp alfa, failing early in its lead trial.

Germany's Merck KGaA said the most important clinical trial testing its cancer drug hopeful bintrafusp alfa, which it is co-developing with GlaxoSmithKline, would be stopped because the treatment does not appear to work.

The U.S. Food and Drug Administration has rejected GlaxoSmithKline's request to weigh in on a key question in lawsuits by women who say the drugmaker failed to warn them that taking the anti-nausea drug Zofran during pregnancy can cause birth defects.

* GSK AND NOVARTIS ANNOUNCE COLLABORATION TO SUPPORT SCIENTIFIC RESEARCH INTO GENETIC DIVERSITY IN AFRICA

* GSK PRESENTS POSITIVE EFFICACY DATA OF DOSTARLIMAB IN MISMATCH REPAIR-DEFICIENT (DMMR) SOLID CANCERS AT ASCO GASTROINTESTINAL CANCERS SYMPOSIUM

* GSK - VIIV HEALTHCARE RECEIVES EU MARKETING AUTHORISATION FOR FIRST-EVER DISPERSIBLE-TABLET FORMULATION OF DOLUTEGRAVIR, TIVICAY

British drugmaker GSK and U.S.-based Vir Biotechnology will evaluate a second antibody-based treatment in patients with mild to moderate COVID-19 in an early- to mid-stage trial, the companies said on Tuesday.

* VIR BIOTECHNOLOGY AND GSK ANNOUNCE NHS-SUPPORTED AGILE STUDY TO EVALUATE VIR-7832 IN EARLY TREATMENT OF COVID-19

* ELIGO BIOSCIENCE SA - ANNOUNCED THAT IT HAS ENTERED INTO A RESEARCH AND OPTION AGREEMENT WITH GLAXOSMITHKLINE Source text for Eikon: Further company coverage:

A federal judge on Friday tossed a slew of claims against major drugmakers in multidistrict litigation over recalled heartburn drug Zantac, finding them preempted by the federal Food, Drug and Cosmetic Act.

Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.

Drugmakers including Pfizer Inc , Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.

* GLAXOSMITHKLINE PLC - VIIV FIRST LONG-ACTING HIV REGIMEN APPROVED IN EU

Japan's Sosei Group Corp said late on Sunday it agreed with GlaxoSmithKline to collaborate on developing treatments for some digestive tract illnesses caused by immune disorders.

* GSK - GSK AND AHREN ANNOUNCE CO-LED SERIES A INVESTMENT IN ADRESTIA

Dozens of professors at major universities are urging the full Federal Circuit U.S. Court of Appeals to review an October panel decision that Teva Pharmaceutical Industries Ltd's generic version of GlaxoSmithKline PLC's heart drug Coreg infringed a GSK patent, even though...

A lawyer for women suing GlaxoSmithKline for failing to warn that taking the anti-nausea drug Zofran during pregnancy can cause birth defects argued on Wednesday that the U.S. Food and Drug Administration's rejection of a warning label does not moot their cases.

Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic.